A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma models

被引：0
|
作者：
Wing Keung Chan
Jessica Williams
Kinnari Sorathia
Betsy Pray
Kaled Abusaleh
Zehua Bian
Archisha Sharma
Ian Hout
Shamama Nishat
Walter Hanel
Shelby L. Sloan
Aneeq Yasin
Nathan Denlinger
Xiaoli Zhang
Natarajan Muthusamy
Sumithira Vasu
Marcos de Lima
Yiping Yang
Robert Baiocchi
Lapo Alinari
机构：
[1] The Ohio State University,Department of Internal Medicine, Division of Hematology, College of Medicine
[2] The Ohio State University,Department of Biomedical Informatics/Center for Biostatistics
来源：
Experimental Hematology & Oncology | / 12卷
关键词：
Mantle cell lymphoma; CD74; Chimeric antigen receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Advances in CD19-targeting CAR-T cell therapies for multiple myeloma
    Steinhardt, Maximilian J.
    Einsele, Hermann
    Waldschmidt, Johannes M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, 25 (01) : 21 - 25
  • [32] Combination Therapy with FTY720 (Fingolimod) and Bispecific Anti-CD20/CD74 Antibodies in Mantle Cell Lymphoma
    Gupta, Pankaj
    Michel, Rosana
    Goldenberg, David M.
    Chang, Chien-Hsing
    BLOOD, 2011, 118 (21) : 1595 - 1595
  • [33] Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies
    Ge, Jianning
    Yang, Chunhui
    Sun, Jing
    Chen, Jiao
    Qiu, Shuyi
    Yin, Wenjie
    Shen, Lianjun
    Sersch, Martina
    Cao, Wei
    Wang, Xinxin
    BLOOD, 2021, 138
  • [34] Sequential CD22 Targeting Impacts CD22 CAR-T Cell Response
    Yates, Bonnie
    Shalabi, Haneen
    Salem, Dalia
    Delbrook, Cynthia
    Yuan, Constance M.
    Stetler-Stevenson, Maryalice
    Fry, Terry J.
    Shah, Nirali N.
    BLOOD, 2018, 132
  • [35] Unmasking the Enigma: A Case Report on Hyponatremia and Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Mantle-Cell Lymphoma
    Matarneh, Ahmad
    Sardar, Sundus
    Portela, Rafael
    Abdulbasit, Muhammad
    Verma, Navin
    Trivedi, Naman
    Ghahramani, Nasrollah
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [36] Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell Development
    Migliorini, Denis
    Mason, Nicola J.
    Posey, Avery D., Jr.
    ILAR JOURNAL, 2018, 59 (03) : 276 - 285
  • [37] Exploring BiTE-Integrated CAR T-Cell Therapy to Overcome Tumor Antigen Escape and Reinforce CAR-T Therapy in Mantle Cell Lymphoma
    Crutchfield, Grace Glass
    Liu, Yang
    Yan, Fangfang
    Li, Xiaolin
    Lee, Heng-Huan
    Wang, Michael
    Yao, Yixin
    BLOOD, 2023, 142
  • [38] Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
    Yuan, Yuncang
    Fan, Jiawei
    Liang, Dandan
    Wang, Shijie
    Luo, Xu
    Zhu, Yongjie
    Liu, Nan
    Xiang, Tingxiu
    Zhao, Xudong
    TRANSLATIONAL ONCOLOGY, 2024, 39
  • [39] Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)
    Li, Xiaofan
    Abrahams, Cristina
    Embry, Millicent
    Yu, Abigail
    Kahana, Jason
    Brown, Michael
    Narla, Rama Krishna
    Barnes, Leo
    Schwartz, Eric
    Boylan, John
    Zawada, James
    Stephenson, Heather
    Bruhns, Maureen
    Bussell, Stuart
    Steiner, Alexander
    Galan, Adam
    Kline, Toni
    Yam, Alice
    Stafford, Ryan
    Hoffmann, Heidi
    Matheny, Shannon
    DeAlmeida, Venita
    Vasquez, Nicki
    Heinsohn, Henry
    Sato, Aaron
    Molina, Arturo
    Hallam, Trevor
    Lupher, Mark, Jr.
    BLOOD, 2016, 128 (22)
  • [40] Evolving patterns of transplant strategies for mantle cell lymphoma in the era of BTK inhibitors and CAR-T therapy
    Maddukuri, Ashok
    Inoue, Yoshitaka
    Rakszawski, Kevin
    Claxton, David
    Ehmann, Christopher
    Zheng, Hong
    Minagawa, Kentaro
    Mineishi, Shin
    Naik, Seema
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345